Huang brings a rare blend of product leadership, customer success, and operational execution across high-growth environments spanning health technology, semiconductors, retail, and communications. She is known for building strong operating rhythms, driving cross-functional alignment, and translating strategy into clear priorities with measurable outcomes. Her approach closely connects customer insight to product direction, helping teams focus on what matters, strengthen adoption, and deliver results that scale.

Strategic technical leadership hire supports expansion of Cercle’s AI platform into broader pharma applications.

Cercle has entered into a strategic partnership with MedITEX, the leading fertility EMR provider in Europe, to distribute its AI platform across MedITEX’s global network of fertility clinics. The partnership will enable clinics using MedITEX to access Cercle’s analytics and predictive tools seamlessly within their existing workflows.

On behalf of the Cercle Board and team, I am excited to welcome Ashley Finch who recently joined the Cercle team. Ashley joins us as our first Chief Operating Officer and will focus on growing our business, leading our go-to-market functions and ensuring we run efficiently and effectively at this critical stage of growth. 

The world is on the verge of the next generation of healthcare. The healthcare industry creates 30% of the world’s data, but up to 80% of that data is unstructured, which means it has been impossible to comprehensively gather, study and learn from our collective medical histories. By unlocking the value of our biomedical and genomics data, we can accelerate the development of precision preventative medicine, help clinicians craft personally-tailored treatments for their patients, and empower everyone to make better, more informed decisions about our health. 

We founded Cercle to advance women’s healthcare and provide unprecedented and secure healthcare insights to clinics, research labs, providers and patients. Women’s healthcare—and particularly, fertility care—is chronically underfunded and under researched, and we believe that must change. We’re working to make this possible through a new, ambitious partnership with genetic analytical services provider Eurofins Genoma.

The world's medical data accounts for at least 30% of all data. That's a ton of lab results, diagnoses, treatment plans and outcomes we could learn from to improve our collective health journey. The big problem standing in the way? Up to 80% of the world’s medical data is unstructured, meaning that information from hospitals and clinics around the world hasn’t been organized cohesively enough. We could learn so much from our medical histories, treatments and paths if there were a clear way to organize and analyze all that medical data.